MZMeng-Yu Zhang

Meng-Yu Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meng-Yu Zhang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Yi Qu

    Department of Geriatrics, Qilu Hospital of Shandong University, Jinan 250012, China; Key Laboratory of Cardiovascular Proteomics of Shandong Province, Jinan 250012, China; Jinan Clinical Research Center for Geriatric Medicine (202132001), Jinan 250012, China

    9 shared publications
  • Rui Li

    Department of Respiratory and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, 250012, China

    5 shared publications
  • Yun-Hong Yin

    Department of Respiratory and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, 250012, China

    5 shared publications
  • Guang Yang

    Department of Pulmonary and Critical Care Medicine, Laboratory of Basic Medical Sciences Qilu Hospital of Shandong University Jinan China

    2 shared publications
  • Jian-Yu Liu

    Key Laboratory of Marine Drugs, The Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China

    2 shared publications
  • Xiao Chen

    Department of Pulmonary and Critical Care Medicine Tai'an City Central Hospital Tai'an China

    2 shared publications

Latest Publications

  • Open Access

    Mendelian Randomization Analysis of the Causal Link Between Rheumatoid Arthritis and Interstitial Lung Disease

    by Mengyu Zhang, Xiao Chen, Wenqing Zhang, Guang Yang, Yunhong Yin, Yiqing Qu

    Background and Objectives: Rheumatoid arthritis (RA) is a systemic autoimmune disease that is often complicated by interstitial lung disease (ILD), one of its most severe extra‐articular manifestations. However, whether RA causally contributes to ILD development remains unclear. Methods: We conducted a two‐sample Mendelian randomization (MR) analysis to investigate whether RA has a causal effect on ILD. MR uses genetic variants associated with RA as instrumental variables to infer causality and minimize confounding. Genetic instruments for RA were obtained from a large European GWAS (ebi‐a‐GCST002318; 14,361 cases and 42,923 controls). The ILD outcome data were derived from FinnGen (finn‐b‐ILD, 1969 ILD cases and 196,986 controls), and autoimmune‐related codes were explicitly excluded to minimize phenotypic overlap. MR analyses were performed using inverse variance weighting (IVW), MR‐Egger regression, weighted median, mode‐based methods, and MR‐PRESSO to assess causality, heterogeneity, and pleiotropy. Results: The MR analysis identified 52 RA‐related single nucleotide polymorphisms (SNPs) ( p < 5 × 10 −8 ), which were selected as instrumental variables. The IVW method revealed a significant causal effect of RA on ILD risk, with an odds ratio (OR) of 1.155 (95% confidence interval [CI]: 1.083–1.232, p = 1.04E‐05). Directionally consistent results were obtained from weighted median and mode‐based methods. The MR‐Egger regression showed no evidence of directional pleiotropy (intercept = 0.014, p = 0.147), and Cochran's Q test detected no significant heterogeneity (IVW Q = 45.424, p = 0.694). Furthermore, the MR‐PRESSO global test did not detect horizontal pleiotropy ( p = 0.26), and no outlier SNPs were identified. Leave‐one‐out analysis indicated that no single SNP disproportionately influenced the overall estimate. The funnel plot showed a symmetrical distribution, suggesting no evidence of directional pleiotropy or influential bias. Conclusion: This MR study provides robust genetic evidence supporting a potential causal relationship between RA and increased risk of ILD. These findings highlight the need for increased clinical vigilance, including early respiratory screening and monitoring in RA patients—particularly those at high risk—to facilitate timely detection and management of ILD. image


  • Open Access

    Identifying the Key Mitochondria‐Related Genes in COPD by Integrating Machine Learning and Bioinformatics Analyses

    by Jiajia Qu, Mengyu Zhang, Yajie Hu, Guang Yang, Xiaoning Zhang, Wenqing Zhang, Yiqing Qu

    Background: Chronic obstructive pulmonary disease (COPD), a prevalent chronic respiratory disorder with high morbidity and mortality, is closely associated with mitochondrial dysfunction and immune dysregulation; however, the underlying mechanisms remain unclear. Aims: The aim of this study is to identify mitochondrial hub genes and evaluate their diagnostic potential in COPD. Methods: This study combined bioinformatics and experimental methods to investigate mitochondria‐related differentially expressed genes (MitoDEGs) in COPD pathogenesis. Two GEO datasets (GSE38974/GSE8545) were analyzed to identify MitoDEGs, which were functionally characterized and refined via machine learning (LASSO/SVM‐RFE). Key genes were further validated using quantitative real‐time polymerase chain reaction (qRT‐PCR) and Western blot in bronchial epithelial cells and COPD mouse model lung tissues. Immune infiltration analysis revealed connections between MitoDEGs and immune dysregulation in COPD that were experimentally confirmed using immunohistochemistry (IHC) and immunofluorescence (IF). Results: Among 28 identified MitoDEGs, five feature genes ( BAX , DLST , FKBP10 , FUNDC2 , and RMDN1 ) were selected. Subsequent validation through qRT‐PCR, Western blot, and ROC curve further confirmed BAX and DLST as core hub genes. Immune profiling revealed significantly increased M0 macrophage infiltration and reduced activated NK cells in COPD. BAX and DLST expression was positively correlated with M0 macrophages but negatively with activated NK cells, a finding corroborated by IHC and IF assays. Conclusions: These findings highlight BAX and DLST as potential mitochondrial dysfunction biomarkers in COPD, linking their roles to immune cell infiltration. This study provides novel insights into cigarette smoke‐induced COPD pathogenesis and underscores the diagnostic utility of targeting mitochondrial–immune interactions.


  • Open Access

    C6 and KLRG2 are pyroptosis subtype-related prognostic biomarkers and correlated with tumor-infiltrating lymphocytes in lung adenocarcinoma

    by Shu-Min Yuan, Xiao Chen, Yi-Qing Qu, Meng-Yu Zhang

    Pyroptosis plays an important role in lung adenocarcinoma (LUAD). In this study, we aimed to explore the pyroptosis-related gene (PRG) expression pattern and to identify promising pyroptosis-related biomarkers to improve the prognosis of LUAD. The gene expression profiles and clinical information of LUAD patients were downloaded from the Cancer Genome Atlas (TCGA), and validation cohort information was extracted from the Gene Expression Omnibus database. Gene expression data were analyzed using the limma package and visualized using the ggplot2 package as well as the pheatmap package in R software. Functional enrichment analysis was also performed for the 44 differentially expressed PRGs (DEPRGs). Then, consensus clustering revealed pyroptosis-related tumor subtypes, and differentially expressed genes (DEGs) were screened according to the subtypes. Next, univariate Cox and multivariate Cox regression analyses were used to identify independent prognostic PRGs. After overlapping DEGs and the Lasso regression analysis-based prognostic genes, the predictive risk model was established and validated. Correlation analysis between PRGs and clinicopathological variables was also explored. Finally, the TIMER and TISIDB databases were used to further explore the correlation analysis between immune cell infiltration levels, the risk score, and clinicopathological variables in the predictive risk model. A total of 52 genes from the PubMed were identified as PRGs, and 44 of the 52 genes were pooled as DEPRGs. The most significant GO term was “collagen trimer” (P = 2.46E-13), and KEGG analysis results indicated that 44 DEPRGs were significantly enriched in Salmonella infection (P < 0.001). Then, consensus clustering analysis divided LUAD patients into two clusters, and a total of 79 DEGs were identified according to these cluster subtypes. Subsequently, univariate and multivariate Cox regression analyses were used to identify 12 genes that could serve as independent prognostic indicators and we also performed Lasso regression analysis and screened 23 DEGs. After overlapping 23 DEGs and 12 genes, only 4 (KLRG2, MAPK4, C6 and SFRP5) of 12 genes were selected for the further exploration of the prognostic pattern. Survival analysis results indicated that this risk model effectively predicted the prognosis (P < 0.001). Combined with the correlation analysis results between the 4 genes and clinicopathological variables, C6 and KLRG2 were screened as prognostic genes. In this study, we constructed a predictive risk model and identified two pyroptosis subtype-related gene expression patterns to improve the prognosis of LUAD. Understanding the subtypes of LUAD is helpful for accurately characterizing the LUAD and developing personalized treatment.


  • Open Access

    Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma

    by Qian Wu, Rui Li, Qing-Xiang Wang, Meng-Yu Zhang, Ting-Ting Liu, Yi-Qing Qu

    Background: Lung adenocarcinoma (LUAD) is a heavy social burden worldwide. Because the mechanisms involved in LUAD remain unclear, the prognosis of LUAD remains poor. Consequently, it is urgent to investigate the potential mechanisms of LUAD. Junctional adhesion molecule-like protein (JAML), is recognized as a tumorigenesis molecule in gastric cancer. However, the role of JAML in LUAD is still unclear. Here we aimed to evaluate the role of JAML in LUAD. Methods: qRT-PCR, Western blotting and immunohistochemistry were conducted to investigate the expression of JAML in LUAD tissues. JAML was knocked down and overexpressed in LUAD cells using transient transfection by siRNA and plasmids or stable transfection by lentivirus. Proliferation potential of LUAD cells were detected by Cell Counting Kit-8, EdU incorporation and Colony formation assay. Migration and invasion abilities of LUAD cells were determined by wound healing, transwell migration and invasion assays. Cell cycle and cell apoptosis were detected by flow cytometry. The effects of JAML in vivo were studied in xenograft tumor models. Western blotting was used to explore the molecular mechanisms of JAML function. In addition, rescue experiments were performed to verify the possible mechanisms. Results: JAML expression was elevated in LUAD tissues compared with peritumor tissues, and this upregulation was positively related to pT and pTNM. Furthermore, both in vitro and in vivo, JAML silencing markedly repressed malignant behaviors of LUAD cells and vice versa. Knockdown of JAML also mediated cell cycle arrest at G0/G1 phase and promoted apoptosis in LUAD cells. Mechanistically, silencing JAML repressed the process of epithelial-mesenchymal transition by inactivating the Wnt/β-catenin pathway in LUAD cells. Effects of JAML can be rescued by Wnt/β-catenin pathway activator in A549 cells. Conclusions: Our data reveal the oncogenic role of JAML in LUAD, indicating that JAML may be a predictive biomarker and novel therapeutic target for LUAD.


  • Open Access

    Comprehensive Bioinformatics Analysis of Lipopolysaccharide‐Induced Altered Autophagy in Acute Lung Injury and Construction of Underlying Competing Endogenous RNA Regulatory Mechanism

    by Jian-Yu Liu, Ying-Xiao Jiang, Meng-Yu Zhang, Chen Huo, Yi-Can Yang, Xiu-Li Ji, Yi-Qing Qu

    Background. Acute lung injury (ALI) is a fatal syndrome frequently induced by lipopolysaccharide (LPS) released from the bacterial cell wall. LPS could also trigger autophagy of lung bronchial epithelial cell to relieve the inflammation, while the overwhelming LPS would impair the balance of autophagy consequently inducing serious lung injury. Methods. We observed the autophagy variation of 16HBE, human bronchial epithelial cell, under exposure to different concentrations of LPS through western blot, immunofluorescence staining, and electron microscopy. Eight strands of 16HBE were divided into two groups upon 1000 ng/ml LPS stimulation or not, which were sent to be sequenced at whole transcriptome. Subsequently, we analyzed the sequencing data in functional enrichment, pathway analysis, and candidate gene selection and constructed a hsa‐miR‐663b‐related competing endogenous RNA (ceRNA) network. Results. We set a series of concentrations of LPS to stimulate 16HBE and observed the variation of autophagy in related protein expression and autophagosome count. We found that the effective concentration of LPS was 1000 ng/ml at 12 hours of exposure and sequenced the 1000 ng/ml LPS‐stimulated 16HBE. As a result, a total of 750 differentially expressed genes (DEGs), 449 differentially expressed lncRNAs (DElncRNAs), 76 differentially expressed circRNAs (DEcircRNAs), and 127 differentially expressed miRNAs (DEmiRNAs) were identified. We constructed the protein‐protein interaction (PPI) network to visualize the interaction between DEGs and located 36 genes to comprehend the core discrepancy between LPS‐stimulated 16HBE and the negative control group. In combined analysis of differentially expressed RNAs (DERNAs), we analyzed all the targeted relationships of ceRNA in DERNAs and figured hsa‐miR‐663b as a central mediator in the ceRNA network to play when LPS induced the variation of autophagy in 16HBE. Conclusion. Our research indicated that the hsa‐miR‐663b‐related ceRNA network may contribute to the key regulatory mechanism in LPS‐induced changes of autophagy and ALI.


  • Open Access

    Serum miR‐1228‐3p and miR‐181a‐5p as Noninvasive Biomarkers for Non‐Small Cell Lung Cancer Diagnosis and Prognosis

    by Wei-Xiao Xue, Meng-Yu Zhang, Rui Li, Xiao Liu, Yun-Hong Yin, Yi-Qing Qu

    Background. Lung cancer is the leading cause of cancer‐related mortality worldwide, and non‐small cell lung cancer (NSCLC) accounts for over 80% of all lung cancers. Serum microRNAs (miRNAs), due to their high stability, have the potential to become valuable noninvasive biomarkers. This present study was aimed to identify the serum miRNAs expression signatures for the diagnosis and prognosis of NSCLC using bioinformatics analysis. Methods. A total of 12 miRNAs profiling studies have been identified in Pubmed, Gene Expression Omnibus (GEO), and ArreyExpress databases. Differentially expressed miRNAs (DEmiRNAs) were analyzed according to GEO2R online tool and RRA method from R. Then, prediction of DEmiRNAs’ target genes from TargetScan, PicTar, miRDB, Tarbase, and miRanda database. Furthermore, we using reverse transcription– quantitative polymerase chain reaction (RT‐qPCR) to evaluate the expression levels of DEmiRNAs in serum samples obtained from NSCLC patients and healthy controls. Subsequently, the clinical significance of the tested miRNAs was determined using receiver operating characteristic (ROC) analysis and Cox regression analysis. Results. A total of 27 DEmiRNAs were identified and 5 of them (miR‐1228‐3p, miR‐1228‐5p, miR‐133a‐3p, miR‐1273f, miR‐545‐3p) were significantly up‐regulated and 4 of them (miR‐181a‐5p, miR‐266‐5p, miR‐361‐5p, miR‐130a‐3p) were significantly down‐regulated in NSCLC patients compared with healthy controls. RT‐qPCR validated that miR‐1228‐3p (P =0.006) and miR‐181a‐5p (P =0.030) were significantly differentially expressed in the serum of NSCLC patients and healthy controls. ROC analysis on miR‐1228‐3p and miR‐181a‐5p revealed the area under the curve (AUC) of 0.685 (95% confidence interval [CI], 0.563–0.806; P =0.006) and 0.647 (95% CI, 0.506–0.758; P =0.049). ROC analysis on miR‐1228‐3p combined miR‐181a‐5p revealed the AUC of 0.711 (95% CI, 0.593–0.828; P =0.002). Multivariate Cox regression analysis demonstrated that the high serum miR‐1228‐3p level was an independent factor for the poor prognosis of NSCLC patients. Conclusions. Serum miR‐1228‐3p and miR‐181a‐5p are potential noninvasive biomarkers for the diagnosis and prognosis of NSCLC patients.


  • Open Access

    Mechanism of YuPingFeng in the Treatment of COPD Based on Network Pharmacology

    by Yunhong Yin, Jianyu Liu, Mengyu Zhang, Rui Li, Xiao Liu, Yican Yang, Yi-Qing Qu

    YuPingFeng (YPF) granules are a classic herbal formula extensively used in clinical practice in China for the treatment of COPD. However, the pathological mechanisms of YPF in COPD remain undefined. In the present research, a network pharmacology‐based strategy was implemented to elucidate the underlying multicomponent, multitarget, and multipathway modes of action of YPF against COPD. First, we identified putative YPF targets based on TCMSP databases and constructed a network containing interactions between putative YPF targets and known therapeutic targets of COPD. Next, two topological parameters, “degree” and “closeness,” were calculated to identify target genes in the network. The major hubs were imported to the MetaCore database for pathway enrichment analysis. In total, 23 YPF active ingredients and 83 target genes associated with COPD were identified. Through protein interaction network analysis, 26 genes were identified as major hubs due to their topological importance. GO and KEGG enrichment analysis results revealed YPF to be mainly associated with the response to glucocorticoids and steroid hormones, with apoptotic and HIF‐1 signalling pathways being dominant and correlative pathways. The promising utility of YPF in the treatment of COPD has been demonstrated by a network pharmacology approach.


  • Open Access

    Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers

    by Rui Li, Yi-E Yang, Yun-Hong Yin, Meng-Yu Zhang, Hao Li, Yi-Qing Qu

    Background: DNA methylation can regulate the role of long noncoding RNAs (lncRNAs) in the development of lung adenocarcinoma (LUAD). The present study aimed to identify methylation-driven lncRNAs and mRNAs as biomarkers in the prognosis of LUAD using bioinformatics analysis. Methods: Differentially expressed RNAs were obtained using the edge R package from 535 LUAD tissues and 59 adjacent non-LUAD tissues. Differentially methylated genes were obtained using the limma R package from 475 LUAD tissues and 32 adjacent non-LUAD tissues. Methylation-driven mRNA and lncRNA were obtained using the MethylMix R package from 465 LUAD tissues with matched DNA methylation and RNA expression and 32 non-LUAD tissues with DNA methylation. Gene ontology and ConsensusPathDB pathway analysis were performed to identify functional enrichment of methylation-driven mRNAs. Univariate and multivariate Cox regression analyses were performed to identify the independent effect of each variable for predicting the prognosis of LUAD. Kaplan–Meier curve analysis of DNA methylation and gene expression might provide potential prognostic biomarkers for LUAD patients. Results: A total of 99 methylation-driven mRNAs and 17 methylation-driven lncRNAs were obtained. Univariate and multivariate Cox regression analysis showed that 6 lncRNAs (FOXE1, HOXB13-AS1_2, VMO1, HIST1H3F, AJ003147.8, ASXL3) were retrieved to construct a predictive model associated with overall survival in LUAD patients. Combined DNA methylation and gene expression survival analysis revealed that 4 lncRNAs (AC023824.1, AF186192.1, LINC01354 and WASIR2) and 8 mRNAs (S1PR1, CCDC181, F2RL1, EFS, KLHDC9, MPV17L, GKN2, ITPRIPL1) might act as independent biomarkers for the prognosis of LUAD. Conclusions: Methylation-driven lncRNA and mRNA contribute to the survival of LUAD, and 4 lncRNAs and 8 mRNAs might be potential biomarkers for the prognosis of LUAD.


  • Open Access

    A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma

    by Xiao-Xia Liu, Yi-E Yang, Xiao Liu, Meng-Yu Zhang, Rui Li, Yun-Hong Yin, Yi-Qing Qu

    Recently, circular RNAs (circRNAs) have been reported to be microRNA sponges and play essential roles in cancer development. This study aimed to evaluate whether circulating circRNAs could be used as diagnostic biomarkers for lung adenocarcinoma (LUAD). The Gene Expression Omnibus (GEO) dataset was used to investigate differentially expressed circRNAs (DEcircRNAs) in paired LUAD tissues and adjacent nontumor tissues. The expression levels of the host genes were analyzed in The Cancer Genome Atlas (TCGA)-LUAD dataset, and the prognostic value was assessed using the Kaplan–Meier plotter. Quantitative real-time PCR (qRT-PCR) was performed to validate the expression of candidate circRNAs in the LUAD plasma and cells. The CCK8 assay was used to measure the function of circRNAs in cell proliferation. Competing endogenous RNA (ceRNA) network, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to predict the possible mechanisms and functions of circRNAs in LUAD. Two upregulated and two downregulated circRNAs were identified as candidate circRNAs using bioinformatics analysis. qRT-PCR demonstrated that hsa_circ_0005962 was upregulated in LUAD plasma and cells, whereas hsa_circ_0086414 was downregulated. Receiver operating characteristic (ROC) curve analysis confirmed that a signature comprising the two circRNAs had good diagnostic potential, with an area under the ROC curve (AUC) of 0.81 (P < 0.0001). In addition, we observed that overexpression of plasma hsa_circ_0086414 was related to EGFR mutations (P = 0.001). Plasma hsa_circ_0005962 displayed significantly different expression before and after surgery in patients with LUAD (P < 0.0001). In vitro experiments suggested that hsa_circ_0005962 promoted LUAD cell proliferation. For future studies, we predicted the circRNA-miRNA-mRNA network for hsa_circ_0005962. Bioinformatics analysis revealed that hsa_circ_0005962 might be involved in LUAD development. A circRNA signature was identified as a potential noninvasive biomarker for LUAD diagnosis.